Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Pancreatitis

Free Subscription Articles published in PLoS One Retrieve available abstracts of 106 articles: HTML format

Single Articles

January 2025
1. NADEEM A, Ashraf R, Mahmood T, Parveen S, et al
   Automated CAD system for early detection and classification of pancreatic cancer using deep learning model.
   PLoS One. 2025;20:e0307900.
   PubMed     Abstract available
   
   
   
2. ABDO E, Ismail MA, Al Hadidi S, Al-Mrahleh M, et al
   Effect of cytotoxic CD8+ T-cells secretory proteins on hypoxic pancreatic cancer cells.
   PLoS One. 2025;20:e0311615.
   PubMed     Abstract available
   
   
   
3. BHATTACHARJEE K, Ghosh A
   Identification of key regulators in pancreatic ductal adenocarcinoma using network theoretical approach.
   PLoS One. 2025;20:e0313738.
   PubMed     Abstract available
   
   
   
4. XIAO X, Huang P, Xu XT
   The choice of adjuvant radiotherapy in pancreatic cancer patients after up-front radical surgery.
   PLoS One. 2025;20:e0317995.
   PubMed     Abstract available
   
   
   
5. WU Q, Liao L, Deng Q
   Association between red blood cell distribution width-to-albumin ratio at admission and all-cause mortality in patients with acute pancreatitis based on the MIMIC-III database.
   PLoS One. 2025;20:e0318873.
   PubMed     Abstract available
   
   
   
6. LIU XW, Zhang YH, Xu L, Xing JB, et al
   Exploring the effects of quercetin-added pancreatic diet on metabolic homeostasis in dogs via metabolomics.
   PLoS One. 2025;20:e0318159.
   PubMed     Abstract available
   
   
   
7. ZHANG Y, Ma H, Wang R, Li L, et al
   Correlation between baseline anion gap and early acute kidney injury in patients with acute pancreatitis in the intensive care unit: A single-center retrospective cohort study.
   PLoS One. 2025;20:e0315386.
   PubMed     Abstract available
   
   
   
8. DING C, Yang JF, Wang X, Zhou YF, et al
   Diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration-based cytology for distinguishing malignant and benign pancreatic cystic lesions: A systematic review and meta-analysis.
   PLoS One. 2025;20:e0314825.
   PubMed     Abstract available
   
   
   
9. HUANG ZH, Zhang J, Xu XY, Wang Y, et al
   Hypnotic drug use and intraoperative fluid balance associated with postoperative delirium following pancreatic surgery: A retrospective, observational, single-center study.
   PLoS One. 2025;20:e0319380.
   PubMed     Abstract available
   
   
   
10. LIAO J, Lu D, Xie H, Wang M, et al
    The role of TyG index as a predictor of all-cause mortality in hospitalized patients with acute pancreatitis: a retrospective study utilizing the MIMIC-IV database.
    PLoS One. 2025;20:e0308994.
    PubMed     Abstract available
    
    
    
11. XIA T, Li J, Liu Z, Jiao X, et al
    Impact of surgical approaches on long-term survival outcomes of patients with pancreatic neuroendocrine carcinoma.
    PLoS One. 2025;20:e0319906.
    PubMed     Abstract available
    
    
    
12. SOLEIMANI Y, Nayebi M, Mahmoudi S, Daraei M, et al
    Cadmium exposure and risk of pancreatic cancer: Systematic review and meta-analysis.
    PLoS One. 2025;20:e0319283.
    PubMed     Abstract available
    
    
    
13. LE KDR, Patel H, Downie E
    A systematic review on the prognostic role of radiologically-proven sarcopenia on the clinical outcomes of patients with acute pancreatitis.
    PLoS One. 2025;20:e0322409.
    PubMed     Abstract available
    
    
    
14. KHANI M, Assadi Shalmani M, Taleban A, Tsai S, et al
    The impact of socioeconomic factors on pancreatic cancer care utilization.
    PLoS One. 2025;20:e0320518.
    PubMed     Abstract available
    
    
    
15. GE H, Wolters-Eisfeld G, Hackert T, Li Y, et al
    Development of a hypoxia-responsive macrophage prognostic model using single-cell and bulk RNA sequencing in pancreatic cancer.
    PLoS One. 2025;20:e0322618.
    PubMed     Abstract available
    
    
    
16. GONZALO-ENCABO P, Gardiner J, Norris MK, Wilson RL, et al
    Resistance exercise combined with protein supplementation for skeletal muscle mass in people with pancreatic cancer undergoing neoadjuvant chemotherapy: Study protocol for the REBUILD trial.
    PLoS One. 2025;20:e0322192.
    PubMed     Abstract available
    
    
    
17. LI W, Li N, Zhan Y, Gu J, et al
    Blood urea nitrogen to albumin ratio as predictor of mortality among acute pancreatitis patients in ICU: A retrospective cohort study.
    PLoS One. 2025;20:e0323321.
    PubMed     Abstract available
    
    
    
18. DENG Q, Yang K, Liao Q, Tang X, et al
    Comprehensive analysis and experiment validation of five cuproptosis-related genes in prognosis, immune infiltration and metabolic characterization of pancreatic cancer.
    PLoS One. 2025;20:e0323458.
    PubMed     Abstract available
    
    
    
19. YANG X, Zhang M, Lv L, Chen X, et al
    Total bilirubin-to-albumin ratio and short- and long-term all-cause mortality in acute pancreatitis: Evidence from the MIMIC-IV database.
    PLoS One. 2025;20:e0323330.
    PubMed     Abstract available
    
    
    
20. PETERS LM, Reding Graf T, Graf R, Mevissen M, et al
    Regenerating island-derived protein 3E concentrations in healthy dogs and dogs with various inflammatory processes.
    PLoS One. 2025;20:e0324090.
    PubMed     Abstract available
    
    
    
21. ISHIKAWA-KAKIYA Y, Maruyama H, Tanoue K, Higashimori A, et al
    Evaluation of the 22G Franseen needle and 22G Lancet needle for endoscopic ultrasonography-guided tissue acquisition sampling in solid pancreatic lesions: Propensity score weighting.
    PLoS One. 2025;20:e0322857.
    PubMed     Abstract available
    
    
    
22. ZHENG Z, Lu Z, Yan F, Song Y, et al
    The role of novel biomarkers in the early diagnosis of pancreatic cancer: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0322720.
    PubMed     Abstract available
    
    
    
23. KIMURA N, Shirai Y, Itoh A, Hirano K, et al
    A multicenter prospective study to determine the optimal range of lymph node dissection in pancreatic cancer surgery after neoadjuvant chemotherapy (LYMRIN-Trial): Project study by the Japan Pancreas Society and JON 2302-P.
    PLoS One. 2025;20:e0325667.
    PubMed     Abstract available
    
    
    
24. NIEDRA H, Rogoza O, Saksis R, Peculis R, et al
    Transcriptomic profiling of pancreatic neuroendocrine tumors: dysregulation of WNT, MAPK, PI3K, neddylation pathways and potential non-invasive biomarkers.
    PLoS One. 2025;20:e0325672.
    PubMed     Abstract available
    
    
    
25. SALGADO-GARZA G, Willy A, Rocha FG, Mayo SC, et al
    The VIPR-1 trial (Visualizing Ischemia in the Pancreatic Remnant): Assessing the role of intraoperative indocyanine green perfusion in predicting postoperative pancreatic leaks and fistulas: Protocol for a phase II clinical trial.
    PLoS One. 2025;20:e0311025.
    PubMed     Abstract available
    
    
    
26. ZHAO H, Li R, Guo X, Kang J, et al
    Mechanism of Plantamajoside in inhibiting ferroptosis of pancreatic beta cells and treatment of T2DM via activation of the xCT/GPX4 pathway.
    PLoS One. 2025;20:e0325674.
    PubMed     Abstract available
    
    
    
27. ZHAN Z, Zheng X, Xu S, Zheng H, et al
    Rising burden of pancreatic cancer in China: Trends, drivers, and future projections.
    PLoS One. 2025;20:e0327009.
    PubMed     Abstract available
    
    
    
28. SUZUKI Y, Sugimori M, Kanemaru Y, Onodera S, et al
    Development of a novel PIK3CA-mutated pancreatic tumor mouse model and evaluation of the therapeutic effects of a PI3K inhibitor.
    PLoS One. 2025;20:e0326491.
    PubMed     Abstract available
    
    
    January 2024
29. EVANS SM, Ivanova K, Cossio D, Pilgrim CHC, et al
    Registry-derived stage (RD-Stage) for capturing stage at diagnosis for pancreatic carcinoma in Australia.
    PLoS One. 2024;19:e0294443.
    PubMed     Abstract available
    
    
    
30. SECHRIST ZR, Lee G, Schwarz EM, Cole CL, et al
    Validation of dual energy X-ray absorptiometry for longitudinal quantification of tumor burden in a murine model of pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0292196.
    PubMed     Abstract available
    
    
    
31. HUANG H, Huang Z, Chen M, Okamoto K, et al
    Evaluation of the therapeutic efficiency and efficacy of blood purification in the treatment of severe acute pancreatitis.
    PLoS One. 2024;19:e0296641.
    PubMed     Abstract available
    
    
    
32. KHRISTENKO E, Sinitsyn V, Rieden T, Girod P, et al
    CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
    PLoS One. 2024;19:e0291185.
    PubMed     Abstract available
    
    
    
33. 
    Retraction: Identification of RegIV as a Novel GLI1 Target Gene in Human Pancreatic Cancer.
    PLoS One. 2024;19:e0298197.
    PubMed    
    
    
    
34. KORDSHOULI SO, Tahmasebi A, Moghadam A, Ramezani A, et al
    A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0289561.
    PubMed     Abstract available
    
    
    
35. 
    Retraction: Epithelial-Mesenchymal Transition Markers and HER3 Expression Are Predictors of Elisidepsin Treatment Response in Breast and Pancreatic Cancer Cell Lines.
    PLoS One. 2024;19:e0298557.
    PubMed    
    
    
    
36. TUSHOSKI-ALEMAN GW, Herremans KM, Underwood PW, Akki A, et al
    Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
    PLoS One. 2024;19:e0297325.
    PubMed     Abstract available
    
    
    
37. DI CARLO P, Serra N, Fasciana TMA, Giammanco A, et al
    Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    PLoS One. 2024;19:e0294049.
    PubMed     Abstract available
    
    
    
38. HUAN L, Yu F, Cao D, Zhou H, et al
    Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2024;19:e0295983.
    PubMed     Abstract available
    
    
    
39. GRIFFIN JI, Chen X, Duan L, Mu Q, et al
    Inoculation of Pan02 cells produces tumor nodules in mouse pancreas: Characterization of a novel orthotopic pancreatic ductal adenocarcinoma tumor model for interventional studies.
    PLoS One. 2024;19:e0300723.
    PubMed     Abstract available
    
    
    
40. LANG H, Lin N, Chen X, Xiang J, et al
    Repressing miR-23a promotes the transdifferentiation of pancreatic alpha cells to beta cells via negatively regulating the expression of SDF-1alpha.
    PLoS One. 2024;19:e0299821.
    PubMed     Abstract available
    
    
    
41. ZHANG C, Lin F, Guo DF, Wang QL, et al
    Assessing the causal link between liver function and acute pancreatitis: A Mendelian randomisation study.
    PLoS One. 2024;19:e0300890.
    PubMed     Abstract available
    
    
    
42. MEHRA T, Lupatsch JE, Kossler T, Dedes K, et al
    Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    PLoS One. 2024;19:e0301271.
    PubMed     Abstract available
    
    
    
43. HAWKINS HJ, Yacob BW, Brown ME, Goldstein BR, et al
    Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
    PLoS One. 2024;19:e0298808.
    PubMed     Abstract available
    
    
    
44. SASAKI Y, Inouchi T, Nakatsuka R, Inoue A, et al
    Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells.
    PLoS One. 2024;19:e0302130.
    PubMed     Abstract available
    
    
    
45. SHEN X, Zhu X, Liu H, Yuan R, et al
    Leveraging genomic signatures of oral microbiome-associated antibiotic resistance genes for diagnosing pancreatic cancer.
    PLoS One. 2024;19:e0302361.
    PubMed     Abstract available
    
    
    
46. DUTTA D, Ray P, De A, Ghosh A, et al
    pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model.
    PLoS One. 2024;19:e0297749.
    PubMed     Abstract available
    
    
    
47. ZHU J, Wu L, Wang Y, Fang M, et al
    Predictive value of the Ranson and BISAP scoring systems for the severity and prognosis of acute pancreatitis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0302046.
    PubMed     Abstract available
    
    
    
48. KIM MC, Kim JH, Jeon SK, Kang HJ, et al
    CT findings and clinical effects of high grade pancreatic intraepithelial neoplasia in patients with intraductal papillary mucinous neoplasms.
    PLoS One. 2024;19:e0298278.
    PubMed     Abstract available
    
    
    
49. HUANG K, Yuan X, Zhao P, He Y, et al
    Effect of chemotherapy on prognosis in patients with primary pancreatic signet ring cell carcinoma: A large real-world study based on machine learning.
    PLoS One. 2024;19:e0302685.
    PubMed     Abstract available
    
    
    
50. HAN X, Hu MN, Ji P, Liu YF, et al
    Construction and alidation of a severity prediction model for acute pancreatitis based on CT severity index: A retrospective case-control study.
    PLoS One. 2024;19:e0303684.
    PubMed     Abstract available
    
    
    
51. AGUILAR DIAZ DE LEON JS, Thirumurty M, Ly N
    Surface plasmon resonance microscopy identifies glycan heterogeneity in pancreatic cancer cells that influences mucin-4 binding interactions.
    PLoS One. 2024;19:e0304154.
    PubMed     Abstract available
    
    
    
52. KUPTAWACH K, Noitung S, Buakeaw A, Puthong S, et al
    Lemon basil seed-derived peptide: Hydrolysis, purification, and its role as a pancreatic lipase inhibitor that reduces adipogenesis by downregulating SREBP-1c and PPAR-gamma in 3T3-L1 adipocytes.
    PLoS One. 2024;19:e0301966.
    PubMed     Abstract available
    
    
    
53. VENDITTELLI P, Bokhorst JM, Smeets EMM, Kryklyva V, et al
    Automatic quantification of tumor-stroma ratio as a prognostic marker for pancreatic cancer.
    PLoS One. 2024;19:e0301969.
    PubMed     Abstract available
    
    
    
54. LIMIJADI EKS, Muniroh M, Prajoko YW, Tjandra KC, et al
    The role of germline BRCA1 & BRCA2 mutations in familial pancreatic cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0299276.
    PubMed     Abstract available
    
    
    
55. SAMARIO-ROMAN J, Velasco M, Larque C, Cardenas-Vazquez R, et al
    NGF effects promote the maturation of rat pancreatic beta cells by regulating GLUT2 levels and distribution, and glucokinase activity.
    PLoS One. 2024;19:e0303934.
    PubMed     Abstract available
    
    
    
56. MIRZAMOHAMADI S, HajiAbbasi MN, Roshandel G, Alimadadi M, et al
    Incidence and risk factors of pancreatic cancer during 15 years follow-up in the Golestan Cohort Study in Iran.
    PLoS One. 2024;19:e0300736.
    PubMed     Abstract available
    
    
    
57. JANTHONGKAW A, Klaophimai S, Khamphaya T, Yimthiang S, et al
    Correction: Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.
    PLoS One. 2024;19:e0305988.
    PubMed     Abstract available
    
    
    
58. UTSUMI M, Inagaki M, Kitada K, Tokunaga N, et al
    Combination of sarcopenia and systemic inflammation-based markers for predicting the prognosis of patients undergoing pancreaticoduodenectomy for pancreatic cancer.
    PLoS One. 2024;19:e0305844.
    PubMed     Abstract available
    
    
    
59. CYSNEIROS MAPC, Cirqueira MB, Barbosa LF, Chaves de Oliveira E, et al
    Immune cells and checkpoints in pancreatic adenocarcinoma: Association with clinical and pathological characteristics.
    PLoS One. 2024;19:e0305648.
    PubMed     Abstract available
    
    
    
60. ECKERS A, Hunsicker O, Spies C, Balzer F, et al
    In vivo effects of balanced, low molecular 6% and 10% hydroxyethyl starch compared with crystalloid volume replacement on the coagulation system in major pancreatic surgery-a sub-analysis of a prospective double-blinded, randomized controlled trial.
    PLoS One. 2024;19:e0303165.
    PubMed     Abstract available
    
    
    
61. MASUM MHU, Wajed S, Hossain MI, Moumi NR, et al
    An mRNA vaccine for pancreatic cancer designed by applying in silico immunoinformatics and reverse vaccinology approaches.
    PLoS One. 2024;19:e0305413.
    PubMed     Abstract available
    
    
    
62. USUI M, Uchida K, Hayasaki A, Kishiwada M, et al
    Prognostic impact of the distance from the anterior surface to tumor cells in pancreatoduodenectomy with neoadjuvant chemoradiotherapy for pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0307876.
    PubMed     Abstract available
    
    
    
63. YANG XJ, Xu YF, Zhu Q
    SPOP expression is associated with tumor-infiltrating lymphocytes in pancreatic cancer.
    PLoS One. 2024;19:e0306994.
    PubMed     Abstract available
    
    
    
64. RAMSEY ML, Heald B, Gokun Y, Baker J, et al
    Germline multigene panel testing in acute and chronic pancreatitis.
    PLoS One. 2024;19:e0307076.
    PubMed     Abstract available
    
    
    
65. YUGE T, Murata Y, Noguchi D, Ito T, et al
    Peritoneal washing cytology status as a crucial prognostic determinant in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection following preoperative chemoradiotherapy.
    PLoS One. 2024;19:e0309834.
    PubMed     Abstract available
    
    
    
66. FRENZEL K, Kayser Y, Hornemann A, Kastner B, et al
    Complementary techniques for the reliable characterisation of tissue samples: A case study on pancreatic tumours analysed by means of X-ray fluorescence analysis and IR spectroscopy.
    PLoS One. 2024;19:e0306795.
    PubMed     Abstract available
    
    
    
67. TAKEDA Y, Yamada D, Kobayashi S, Sasaki K, et al
    MicroRNA-26a-5p is a reliable biomarker in the adjuvant setting for pancreatic ductal adenocarcinoma.
    PLoS One. 2024;19:e0310328.
    PubMed     Abstract available
    
    
    
68. YOSHIMOTO M, Hayakawa T, Yamaguchi M, Kimura S, et al
    alphavbeta3 integrin-targeted magnetic resonance imaging in a pancreatic cancer mouse model using RGD-modified liposomes encapsulated with Fe-deferoxamine.
    PLoS One. 2024;19:e0310984.
    PubMed     Abstract available
    
    
    
69. HUANG X, Li H, Zhao L, Xu L, et al
    Prediabetes increases the risk of pancreatic cancer: A meta-analysis of longitudinal observational studies.
    PLoS One. 2024;19:e0311911.
    PubMed     Abstract available
    
    
    
70. 
    Retraction: Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer.
    PLoS One. 2024;19:e0313436.
    PubMed    
    
    
    
71. GONG G, Wu Y, Jiang Y, Cao Y, et al
    Integrated global and unique metabolic characteristics to reveal the intervention effect of Yiyi decoction on acute pancreatitis.
    PLoS One. 2024;19:e0310689.
    PubMed     Abstract available
    
    
    
72. CHEN SY, Song XJ, Lu JT, Liang JX, et al
    Application of alkaline phosphatase-to-hemoglobin and lactate dehydrogenase-to-hemoglobin ratios as novel noninvasive indices for predicting severe acute pancreatitis in patients.
    PLoS One. 2024;19:e0312181.
    PubMed     Abstract available
    
    
    
73. WEI X, Weng Z, Xu X, Yao J, et al
    Exploration of a miRNA-mRNA network shared between acute pancreatitis and Epstein-Barr virus infection by integrated bioinformatics analysis.
    PLoS One. 2024;19:e0311130.
    PubMed     Abstract available
    
    
    
74. KOO BW, Oh AY, Na HS, Han J, et al
    Goal-directed fluid therapy on the postoperative complications of laparoscopic hepatobiliary or pancreatic surgery: An interventional comparative study.
    PLoS One. 2024;19:e0315205.
    PubMed     Abstract available
    
    
    
75. 
    Retraction: Net Expression Inhibits the Growth of Pancreatic Ductal Adenocarcinoma Cell PL45 In Vitro and In Vivo.
    PLoS One. 2024;19:e0315984.
    PubMed    
    
    
    
76. MEHRA T, Lupatsch JE, Koessler T, Dedes K, et al
    Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    PLoS One. 2024;19:e0315976.
    PubMed     Abstract available
    
    
    
77. BONDE M, Bonde A, Kaafarani H, Millarch A, et al
    Assessing the value of deep neural networks for postoperative complication prediction in pancreaticoduodenectomy patients.
    PLoS One. 2024;19:e0316402.
    PubMed     Abstract available
    
    
    January 2023
78. TIAN W, Zhang L, Liu X, Ma X, et al
    Fluoropyrimidine combination therapy versus fluoropyrimidine monotherapy for gemcitabine-refractory advanced pancreatic cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0282360.
    PubMed     Abstract available
    
    
    
79. LARIVUO I, Laukkala H, Nevalainen A, Arponen O, et al
    Psychiatric medications and the risk of autoimmune and immune-mediated inflammatory diseases: A systematic review and meta-analysis of observational studies.
    PLoS One. 2023;18:e0281979.
    PubMed     Abstract available
    
    
    
80. BASNET S, Ghimire MP, Lamichhane TR, Adhikari R, et al
    Identification of potential human pancreatic alpha-amylase inhibitors from natural products by molecular docking, MM/GBSA calculations, MD simulations, and ADMET analysis.
    PLoS One. 2023;18:e0275765.
    PubMed     Abstract available
    
    
    
81. WANG L, Luo P, Yang Z, Zhong X, et al
    FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression.
    PLoS One. 2023;18:e0280794.
    PubMed     Abstract available
    
    
    
82. POUDEL SK, Padmanabhan R, Dave H, Guinta K, et al
    Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease.
    PLoS One. 2023;18:e0283021.
    PubMed     Abstract available
    
    
    
83. CHEN Q, Lin J, Chen Z, Che L, et al
    Circular RNA expression alterations and function prediction in OSA-induced pancreatic injury in mice: New insights into pathogenesis.
    PLoS One. 2023;18:e0284459.
    PubMed     Abstract available
    
    
    
84. HENG X, Chen B, Zhao K, Li J, et al
    Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
    PLoS One. 2023;18:e0284930.
    PubMed     Abstract available
    
    
    
85. SHIM JY, Chung JO, Jung D, Kang PS, et al
    Parkin-mediated mitophagy is negatively regulated by FOXO3A, which inhibits Plk3-mediated mitochondrial ROS generation in STZ diabetic stress-treated pancreatic beta cells.
    PLoS One. 2023;18:e0281496.
    PubMed     Abstract available
    
    
    
86. XIAO X, Wu X, Fu Q, Ren X, et al
    Efficacy and safety of Dachaihu Decoction for acute pancreatitis: Protocol for a systematic review and meta-analysis.
    PLoS One. 2023;18:e0285661.
    PubMed     Abstract available
    
    
    
87. DIKE CR, Sun QK, Rahib L, Golden M, et al
    Extra-pancreatic manifestations reported in association with pancreatitis; an international survey report.
    PLoS One. 2023;18:e0288337.
    PubMed     Abstract available
    
    
    
88. AMINI M, Azizmohammad Looha M, Rahimi Pordanjani S, Asadzadeh Aghdaei H, et al
    Global long-term trends and spatial cluster analysis of pancreatic cancer incidence and mortality over a 30-year period using the global burden of disease study 2019 data.
    PLoS One. 2023;18:e0288755.
    PubMed     Abstract available
    
    
    
89. LING R, Liang J, Mo S, Qi J, et al
    Physical activity, sedentary behavior and pancreatitis risk: Mendelian randomization study.
    PLoS One. 2023;18:e0287810.
    PubMed     Abstract available
    
    
    
90. SHIMAGAKI T, Sugimachi K, Mano Y, Tomino T, et al
    A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma.
    PLoS One. 2023;18:e0288033.
    PubMed     Abstract available
    
    
    
91. HEINZMAN C, Hornung L, Lin TK, Lowe CMO, et al
    Total pancreatectomy with islet autotransplantation reduces opioid use and improves nutritional support in children with debilitating pancreatitis.
    PLoS One. 2023;18:e0289620.
    PubMed     Abstract available
    
    
    
92. KAUR G, Helmer RA, Martinez-Marin D, Sennoune SR, et al
    Helicase-like transcription factor (Hltf)-deletion activates Hmgb1-Rage axis and granzyme A-mediated killing of pancreatic beta cells resulting in neonatal lethality.
    PLoS One. 2023;18:e0286109.
    PubMed     Abstract available
    
    
    
93. ZHANG Y, Kirk CA, Tolbert MK, Steiner JM, et al
    Impact of fatty acid composition on markers of exocrine pancreatic stimulation in dogs.
    PLoS One. 2023;18:e0290555.
    PubMed     Abstract available
    
    
    
94. LIU S, Li H, Xue Y, Yang L, et al
    Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0290888.
    PubMed     Abstract available
    
    
    
95. LAPIN M, Tjensvoll K, Nedrebo K, Taksdal E, et al
    Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.
    PLoS One. 2023;18:e0291623.
    PubMed     Abstract available
    
    
    
96. JANTHONGKAW A, Klaophimai S, Khampaya T, Yimthiang S, et al
    Effect of Green and Red Thai Kratom (Mitragyna speciosa) on pancreatic digestive enzymes (alpha-glucosidase and lipase) and acetyl-carboxylase 1 activity: A possible therapeutic target for obesity prevention.
    PLoS One. 2023;18:e0291738.
    PubMed     Abstract available
    
    
    
97. 
    Ex pression of Concern: Different Patterns of Akt and ERK Feedback Activation in Response to Rapamycin, Active-Site mTOR Inhibitors and Metformin in Pancreatic Cancer Cells.
    PLoS One. 2023;18:e0292422.
    PubMed    
    
    
    
98. AZEVEDO-POULY A, Hale MA, Swift GH, Hoang CQ, et al
    Key transcriptional effectors of the pancreatic acinar phenotype and oncogenic transformation.
    PLoS One. 2023;18:e0291512.
    PubMed     Abstract available
    
    
    
99. BRAYER KJ, Hanson JA, Cingam S, Martinez C, et al
    The inflammatory response of human pancreatic cancer samples compared to normal controls.
    PLoS One. 2023;18:e0284232.
    PubMed     Abstract available
    
    
    
100. INGLE K, LaComb JF, Graves LM, Baines AT, et al
     AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
     PLoS One. 2023;18:e0294065.
     PubMed     Abstract available
     
     
     
101. 
     Retraction: Expression of DNMT1 and DNMT3a Are Regulated by GLI1 in Human Pancreatic Cancer.
     PLoS One. 2023;18:e0294385.
     PubMed    
     
     
     
102. GANDIKOTA HP, S A, M SK
     CT scan pancreatic cancer segmentation and classification using deep learning and the tunicate swarm algorithm.
     PLoS One. 2023;18:e0292785.
     PubMed     Abstract available
     
     
     
103. 
     Expression of Concern: Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
     PLoS One. 2023;18:e0294622.
     PubMed    
     
     
     
104. DAILEY KM, Small JM, Pullan JE, Winfree S, et al
     An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic.
     PLoS One. 2023;18:e0289183.
     PubMed     Abstract available
     
     
     
105. KARBHARI A, Mosessian S, Trivedi KH, Valla F Jr, et al
     Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
     PLoS One. 2023;18:e0294564.
     PubMed     Abstract available
     
     
     
106. KANAPARTHY NS, Loza AJ, Hauser RG
     Crawling toward obsolescence: The extended lifespan of amylase for pancreatitis.
     PLoS One. 2023;18:e0296180.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.